Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period

NAActive, not recruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

December 8, 2024

Study Completion Date

February 7, 2025

Conditions
Cardiovascular Diseases
Interventions
DEVICE

The AngioliteTM Durable Fluoroacrylate Polymer-based Sirolimus-Eluting Stent

The Angiolite stent is a thin-strut cobalt-chromium sirolimus-eluting stent with an open-cell design and a high overexpansion capacity that might overcomes some of these challenges in LMCA PCI. The ANGIOLITE randomized trial confirmed the non-inferiority of the Angiolite stent against the conventional DES

Trial Locations (1)

999077

The Chinese University of Hong Kong, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER